Donald J. Zandier, Jr., Pc Psychologist Medicare: Medicare Enrolled Practice Location: 2940 S Park Rd, Suite 102, Bethel Park, PA 15102 Phone: 412-833-1800 Fax: 412-833-1818 |
St Clair Medical Services, Inc. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2000 Oxford Dr Ste 405, Bethel Park, PA 15102 Phone: 412-942-6300 Fax: 412-942-6322 |
John V. Vinay, Lpc, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2884 Industrial Blvd, Suite #7, Bethel Park, PA 15102 Phone: 412-952-9460 |
New Waters Counseling Llc Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3400 S Park Rd Ste 9, Bethel Park, PA 15102 Phone: 412-368-3443 |
News Archive
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Ewing sarcoma is a bone cancer that appears mainly in teenagers. Due to a single defective gene, once it spreads to distant organs it is hard to treat. Researchers at the Weizmann Institute of Science have discovered molecular interactions underlying Ewing sarcomas and proposed a potential treatment, which has shown promise in a study in mice.
The Washington Post reported that President Barack Obama had a slight edge in the polls, but most analysts expect the election to be extremely close. GOP challenger Mitt Romney continued to hammer his anti-Obamacare message while other news outlets predict that whoever wins will face big challenges in dealing with the deficit.
John Muir Health is offering a new cancer treatment option using the latest technology from Varian Medical Systems - The Trilogy Linear Accelerator with RapidArc Technology. The new accelerator, located at John Muir Medical Center, Concord, significantly shortens treatment sessions from 15-20 minutes to 2-5 minutes, while improving the precision of the radiotherapy.
The notion of a pain switch is an alluring idea, but is it realistic? Well, chemists at LMU Munich, in collaboration with colleagues in Berkeley and Bordeaux, have now shown in laboratory experiments that it is possible to inhibit the activity of pain-sensitive neurons using an agent that acts as a photosensitive switch. For the LMU researchers, the method primarily represents a valuable tool for probing the neurobiology of pain.
› Verified 8 days ago